Category: neuroendocrine tumors

Fructose vs. Glucose: The Effect of Sugars on Cancer Cells

All sugars are not the same when it comes to cancer cells, according to a newly published study by Dr. Anthony Heaney, endocrinologist and neuroendocrine tumor specialist, and his colleagues at UCLA.  The study found that fructose caused pancreatic …

12 iPhone Apps for Patients and Physicians

For carcinoid and neuroendocrine cancer iPhone users there are many resources for you as a patient or for your physician that have been created by big pharmaceutical companies around the world.  These pharma companies include Novartis, Pfizer, Merck…

Goblet Cell Carcinoid: New Article in the World Journal of Gastrointestinal Oncology

“Goblet Cell Carcinoid Tumors of the Appendix: An Overview,” by Paromita Roy, Department of Pathology at the University of Toronto in Canada, and Runjan Chetty, Department of Pathology at the University of Glasgow in Scotland, has been published in …

Clinical Trial for Patients with Advanced Pancreatic Neuroendocrine Tumors Shows Significant Improvement in Progression-Free Survival

An important development in the treatment of cancer patients with advanced pancreatic neuroendocrine tumors (pNET) was presented at the ESMO Conference:  12th World Congress on Gastrointestinal Cancer, held in Barcelona, Spain from June 30 through…

Happy 4th of July from The Carcinoid Cancer Foundation

Only 3 Days Left to Register for Carcinoid NET Patient Conference in California

There are only a few spots left and registration closes on July 5 for the 2010 San Francisco Carcinoid and Neuroendocrine Tumor Patient Conference, sponsored by InterScience Institute (ISI) and the Carcinoid Cancer Awareness Network (CCAN).  Join …

Is It Irritable Bowel Syndrome or Carcinoid Cancer? Think Zebras, Not Horses

So often misdiagnosed as irritable bowel syndrome or Crohn’s disease, carcinoid cancer is a diagnosis where doctors are thinking zebras not horses.  The saying goes back to medical school when students are taught to consider the uncommon.  “Ninety-nine…

Advocacy Award Honors the Late Monica Warner of the Carcinoid Cancer Foundation: Call for Nominations

Novartis Oncology has announced its 2010 Warner Advocacy Award named in honor of Monica Warner, a driving force behind the Carcinoid Cancer Foundation for two decades and an extraordinary advocate for carcinoid and neuroendocrine tumor patients. …

Clinical Trials Resources for Carcinoid Cancer & Neuroendocrine Tumor Patients

Carcinoid and neuroendocrine tumor patients can have the latest information about clinical trials delivered directly to their computers – by RSS feed or e-mail.  Go to https://clinicaltrials.gov/, in the search field enter the type of trial you are…

Lung Carcinoid Survivor Runs Marathon in California

When Kenneth Todd asked his surgeon how the removal of his left lung would affect his daily activities, the surgeon told him he could do everything except run a marathon.  Mr. Todd, who had never previously been a runner, decided he had a new goal.  In 2006,…